Apotex Inc. v. Boehringer lngelheim Pharmaceuticals, Inc. et al
| Apotex Inc. |
| Boehringer lngelheim Pharmaceuticals, Inc., Boehringer lngelheim International GMBH, Boehringer lngelheim Corporation and Boehringer lngelheim Pharma GMBH & Co.KG. |
| 1:2023cv00704 |
| June 28, 2023 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 25, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 18 PROPOSED CONSENT JUDGMENT by Apotex Inc.. (Phillips, John) |
| Filing 17 STIPULATION TO EXTEND TIME for Defendants to respond to the Complaint (D.I. 2) to August 25, 2023 - filed by Boehringer lngelheim Corporation, Boehringer lngelheim International GMBH, Boehringer lngelheim Pharma GMBH & Co.KG., Boehringer lngelheim Pharmaceuticals, Inc.. (Dellinger, Megan) |
SO ORDERED, re #17 STIPULATION TO EXTEND TIME for Defendants to respond to the Complaint (D.I. #2 ) to August 25, 2023. Set/Reset Answer Deadlines: Boehringer lngelheim Corporation answer due 8/25/2023; Boehringer lngelheim International GMBH answer due 8/25/2023; Boehringer lngelheim Pharma GMBH & Co.KG. answer due 8/25/2023; Boehringer lngelheim Pharmaceuticals, Inc. answer due 8/25/2023. ORDERED by Judge Maryellen Noreika on 8/18/2023. (mdb)
|
|
SO ORDERED re #16 STIPULATION TO EXTEND TIME for Boehringer to respond to Apotex's Complaint (D.I. 2) to August 18, 2023 (Set/Reset Answer Deadlines: Boehringer lngelheim Corporation answer due 8/18/2023; Boehringer lngelheim International GMBH answer due 8/18/2023; Boehringer lngelheim Pharma GMBH & Co.KG. answer due 8/18/2023; Boehringer lngelheim Pharmaceuticals, Inc. answer due 8/18/2023). ORDERED by Judge Maryellen Noreika on 8/14/2023. (dlw)
|
| Filing 16 STIPULATION TO EXTEND TIME for Boehringer to respond to Apotex's Complaint (D.I. 2) to August 18, 2023 - filed by Boehringer lngelheim Corporation, Boehringer lngelheim International GMBH, Boehringer lngelheim Pharma GMBH & Co.KG., Boehringer lngelheim Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
|
SO ORDERED re #15 MOTION for Pro Hac Vice Appearance of Attorney Rachel Pernic Waldron and Greg L. Goldblatt filed by Apotex Inc. ORDERED by Judge Maryellen Noreika on 8/8/2023. (dlw)
|
| Pro Hac Vice Attorney Greg L. Goldblatt for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) |
| Pro Hac Vice Attorney Rachel P. Waldron for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) |
| Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Rachel Pernic Waldron and Greg L. Goldblatt - filed by Apotex Inc.. (Attachments: #1 Certification of Rachel Pernic Waldron, #2 Certification of Greg L. Goldblatt)(Haney, Megan) |
| Pro Hac Vice Attorney William A. Rakoczy for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) |
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy and Steven J. Birkos filed by Apotex Inc.. ORDERED by Judge Maryellen Noreika on 8/2/2023. (mdb)
|
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy and Steven J. Birkos - filed by Apotex Inc.. (Attachments: #1 Certification of William A. Rakoczy, #2 Certification of Steven J. Birkos)(Haney, Megan) |
|
SO ORDERED re #13 STIPULATION TO EXTEND TIME for Boehringer to respond to Apotex's Complaint (D.I. 2) to August 11, 2023 (Set/Reset Answer Deadlines: Boehringer lngelheim Corporation answer due 8/11/2023; Boehringer lngelheim International GMBH answer due 8/11/2023; Boehringer lngelheim Pharma GMBH & Co.KG. answer due 8/11/2023; Boehringer lngelheim Pharmaceuticals, Inc. answer due 8/11/2023). ORDERED by Judge Maryellen Noreika on 7/27/2023. (dlw)
|
| Filing 13 STIPULATION TO EXTEND TIME for Boehringer to respond to Apotex's Complaint (D.I. 2) to August 11, 2023 - filed by Boehringer lngelheim Corporation, Boehringer lngelheim International GMBH, Boehringer lngelheim Pharma GMBH & Co.KG., Boehringer lngelheim Pharmaceuticals, Inc.. (Egan, Brian) |
| Filing 12 SUMMONS Returned Executed by Apotex Inc..Boehringer lngelheim International GMBH served on 7/7/2023, answer due 7/28/2023. (Haney, Megan) |
| Filing 11 SUMMONS Returned Executed by Apotex Inc..Boehringer lngelheim Pharma GMBH & Co.KG. served on 7/7/2023, answer due 7/28/2023. (Haney, Megan) |
| Filing 10 AFFIDAVIT of Service for Complaint, Summons and Related Papers served on Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals, Inc. on July 5, 2023 and July 6, 2023, filed by Apotex Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Haney, Megan) |
| Filing 9 REDACTED VERSION of #2 Complaint, by Apotex Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Civil Cover Sheet)(Phillips, John) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Remark: Case submitted for judicial routine assignment. (vfm) |
|
Filing 8
ORAL ORDER: IT IS HEREBY ORDERED that Plaintiff's Motion for Leave to File the Complaint Under Seal (D.I. 1) is GRANTED. IT IS ALSO HEREBY ORDERED that, no later than Thursday, July 6, 2023, Plaintiff shall file a redacted version of the Complaint. Ordered by Judge Gregory B. Williams on 6/29/2023. (etg)
|
| Filing 7 Summons Issued as to Boehringer lngelheim Corporation on 6/28/2023; Boehringer lngelheim International GMBH on 6/28/2023; Boehringer lngelheim Pharma GMBH & Co.KG. on 6/28/2023; Boehringer lngelheim Pharmaceuticals, Inc. on 6/28/2023. (Attachments: #1 Summons Issued, #2 Summons Issued, #3 Summons Issued) (vfm) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings Inc., Corporate Parent Artemis Intermediate Holdings, Inc. for Apotex Inc. filed by Apotex Inc.. (vfm) |
| Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,673,927 ;8,846,695 ;8,883,805. (vfm) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/10/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/10/2025. (vfm) |
| Filing 3 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 2 [SEALED] COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Boehringer lngelheim Corporation, Boehringer lngelheim International GMBH, Boehringer lngelheim Pharma GMBH & Co.KG., Boehringer lngelheim Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number 1238.) - filed by Apotex Inc.. (Attachments: #1 Civil Cover Sheet, #2 Exhibit A-E) (vfm) |
| Filing 1 MOTION to Seal - filed by Apotex Inc.. (Attachments: #1 Text of Proposed Order) (vfm) |
| Remark: Exit electronic copies to Duty Judge GBW. (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
